+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Uveitis Treatment Market by Treatment Type, Disease Type, Cause, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5888962
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Uveitis Treatment Market grew from USD 724.65 million in 2023 to USD 783.24 million in 2024. It is expected to continue growing at a CAGR of 8.48%, reaching USD 1.28 billion by 2030.

The scope of market research for uveitis treatment at 360iResearch involves analyzing medications, biologics, and surgical interventions aimed at addressing uveitis, an inflammatory eye condition affecting the uvea. The necessity of this research is underscored by the growing prevalence of uveitis, which can lead to severe complications like cataracts and glaucoma if left untreated. End-use applications span from hospitals and clinics to research laboratories focused on developing newer therapeutic modalities. Key growth factors influencing this market include technological advancements in biologics, increasing awareness about eye diseases, and the availability of diverse treatment options. Additionally, a growing global aging population and rising instances of autoimmune disorders contribute to expanding market opportunities. Current opportunities lie in the development of novel biologics and personalized medicine approaches, aligning treatments more closely with patient-specific pathologies. Companies can capitalize on these trends by investing in precision medicine and enhancing drug delivery systems for improved patient compliance. Nevertheless, challenges such as high treatment costs, insurance coverage limitations, and stringent regulatory hurdles present barriers to market expansion. The competitive landscape is highly dynamic, encouraging innovation in minimally invasive treatments and the exploration of off-label uses for existing drugs to broaden their therapeutic scope. Research in gene therapy and the development of long-acting drug formulations are potential areas of innovation, promising significant business growth and offering insights into future market trajectories. Despite these advancements, market players must navigate issues related to clinical efficacy, potential side effects, and ensuring affordable access to treatments, all while adhering to regulatory compliance. Overall, strategic collaborations between pharmaceutical companies and research institutions, accompanied by robust R&D investments, will be crucial in harnessing the market's full potential while addressing its inherent limitations and challenges.

Understanding Market Dynamics in the Uveitis Treatment Market

The Uveitis Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising aging population and increasing prevalence of chronic eye disorders
    • Advancement in diagnostic techniques for imaging uveitis
    • Technical improvement in drug delivery methods
  • Market Restraints
    • Long-term treatment and huge treatment costs
  • Market Opportunities
    • Ongoing research and development for innovative treatment therapies
    • Emergence of telemedicine and remote monitoring of patients
  • Market Challenges
    • Side-effects associated with the usage of systemic immunosuppressive medications

Exploring Porter’s Five Forces for the Uveitis Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Uveitis Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Uveitis Treatment Market

External macro-environmental factors deeply influence the performance of the Uveitis Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Uveitis Treatment Market

The Uveitis Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Uveitis Treatment Market

The Uveitis Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Uveitis Treatment Market

The Uveitis Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Uveitis Treatment Market, highlighting leading vendors and their innovative profiles. These include Accutome, Inc., Ajanta Pharma Ltd., Alcon Vision LLC, Allergan PLC, Amorphex Therapeutics Holdings, Inc., Appasamy Ocular Device Pvt Ltd., Astellas Pharma Inc., Bausch & Lomb Incorporated, Bayer AG, Cipla Ltd., Entod Pharmaceuticals Ltd., EyePoint Pharmaceuticals, Inc., Fera Pharmaceuticals, His Eyeness Ophthalmics Pvt Ltd., Intas Pharmaceuticals Ltd., J B Chemicals And Pharmaceuticals Ltd., Kubota Vision Inc., Merck & Co. Inc., Micro Labs Ltd., Nidek Co Ltd., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Sunways India Pvt Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Uveitis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment Type
    • Analgesics
    • Antibiotics
    • Antifungal
    • Antivirals
    • Corticosteroids
    • Cycloplegic Agents
    • Immunosuppressant
    • Monoclonal Antibodies
  • Disease Type
    • Anterior Uveitis
    • Intermediate Uveitis
    • Panuveitis
    • Posterior Uveitis
  • Cause
    • Infectious
    • Noninfectious
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising aging population and increasing prevalence of chronic eye disorders
5.1.1.2. Advancement in diagnostic techniques for imaging uveitis
5.1.1.3. Technical improvement in drug delivery methods
5.1.2. Restraints
5.1.2.1. Long-term treatment and huge treatment costs
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for innovative treatment therapies
5.1.3.2. Emergence of telemedicine and remote monitoring of patients
5.1.4. Challenges
5.1.4.1. Side-effects associated with the usage of systemic immunosuppressive medications
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Uveitis Treatment Market, by Treatment Type
6.1. Introduction
6.2. Analgesics
6.3. Antibiotics
6.4. Antifungal
6.5. Antivirals
6.6. Corticosteroids
6.7. Cycloplegic Agents
6.8. Immunosuppressant
6.9. Monoclonal Antibodies
7. Uveitis Treatment Market, by Disease Type
7.1. Introduction
7.2. Anterior Uveitis
7.3. Intermediate Uveitis
7.4. Panuveitis
7.5. Posterior Uveitis
8. Uveitis Treatment Market, by Cause
8.1. Introduction
8.2. Infectious
8.3. Noninfectious
9. Uveitis Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Uveitis Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Uveitis Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Uveitis Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. UVEITIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. UVEITIS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL UVEITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UVEITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. UVEITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. UVEITIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL UVEITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. UVEITIS TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANTERIOR UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTERMEDIATE UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY POSTERIOR UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY NONINFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. CANADA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 44. CANADA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. MEXICO UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. CHINA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. CHINA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 65. CHINA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 66. CHINA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. INDIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. INDIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 70. INDIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. JAPAN UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. JAPAN UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 77. JAPAN UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 78. JAPAN UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. THAILAND UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. THAILAND UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. THAILAND UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 102. THAILAND UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 114. DENMARK UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 115. DENMARK UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. EGYPT UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 118. EGYPT UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. FINLAND UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 122. FINLAND UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. FRANCE UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. GERMANY UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 130. GERMANY UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. ITALY UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. ITALY UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 138. ITALY UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 139. ITALY UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. NORWAY UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. NORWAY UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 150. NORWAY UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. POLAND UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 153. POLAND UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 154. POLAND UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 155. POLAND UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. QATAR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 157. QATAR UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 158. QATAR UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 159. QATAR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SPAIN UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 174. SPAIN UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. TURKEY UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 185. TURKEY UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 186. TURKEY UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 187. TURKEY UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM UVEITIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM UVEITIS TREATMENT MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. UVEITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 197. UVEITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Uveitis Treatment Market, which are profiled in this report, include:
  • Accutome, Inc.
  • Ajanta Pharma Ltd.
  • Alcon Vision LLC
  • Allergan PLC
  • Amorphex Therapeutics Holdings, Inc.
  • Appasamy Ocular Device Pvt Ltd.
  • Astellas Pharma Inc.
  • Bausch & Lomb Incorporated
  • Bayer AG
  • Cipla Ltd.
  • Entod Pharmaceuticals Ltd.
  • EyePoint Pharmaceuticals, Inc.
  • Fera Pharmaceuticals
  • His Eyeness Ophthalmics Pvt Ltd.
  • Intas Pharmaceuticals Ltd.
  • J B Chemicals And Pharmaceuticals Ltd.
  • Kubota Vision Inc.
  • Merck & Co. Inc.
  • Micro Labs Ltd.
  • Nidek Co Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Sunways India Pvt Ltd.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information